Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, David Kremer, Jens Ingwersen et al.|Journal of Neurology Neurosurgery & Psychiatry|2022Cited by 30
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, David Kremer, Kristin S. Golombeck et al.|Frontiers in Immunology|2022Cited by 9